Adial Pharmaceuticals (NASDAQ:ADIL) Posts Quarterly Earnings Results, Misses Estimates By $0.20 EPS
Adial Pharmaceuticals (NASDAQ:ADIL – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.59) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.39) by ($0.20), Zacks reports. Adial Pharmaceuticals Price Performance Shares of ADIL stock remained flat at $0.97 on Thursday. 167,506 shares of the stock traded […]
More Stories
Valence8 US LP Takes $268,000 Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Valence8 US LP bought a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the third quarter, Holdings...
Valence8 US LP Takes $268,000 Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Valence8 US LP bought a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the third quarter, Holdings...
Martin Marietta Materials, Inc. (NYSE:MLM) Stock Position Cut by Lathrop Investment Management Corp
Lathrop Investment Management Corp decreased its position in Martin Marietta Materials, Inc. (NYSE:MLM – Free Report) by 2.5% in the...
Martin Marietta Materials, Inc. (NYSE:MLM) Stock Position Cut by Lathrop Investment Management Corp
Lathrop Investment Management Corp decreased its position in Martin Marietta Materials, Inc. (NYSE:MLM – Free Report) by 2.5% in the...
AlphaCore Capital LLC Acquires 189 Shares of Blackstone Inc. (NYSE:BX)
AlphaCore Capital LLC increased its holdings in Blackstone Inc. (NYSE:BX – Free Report) by 1.6% in the 3rd quarter, according...
AlphaCore Capital LLC Acquires 189 Shares of Blackstone Inc. (NYSE:BX)
AlphaCore Capital LLC increased its holdings in Blackstone Inc. (NYSE:BX – Free Report) by 1.6% in the 3rd quarter, according...